AGTR2 and diabetic kidney disease: Key overlap of ARB effect with DKD pathophysiology are shown in Fig. 2c, at first including the drug target angiotensin II receptor, type 2 (AGTR2) together with the bradykinin system and the NFκB/PPARγ axis.